These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 8275464

  • 1. Evidence for the existence of a third progesterone receptor protein in human breast cancer cell line T47D.
    Wei LL, Miner R.
    Cancer Res; 1994 Jan 15; 54(2):340-3. PubMed ID: 8275464
    [Abstract] [Full Text] [Related]

  • 2. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP.
    Sartorius CA, Groshong SD, Miller LA, Powell RL, Tung L, Takimoto GS, Horwitz KB.
    Cancer Res; 1994 Jul 15; 54(14):3868-77. PubMed ID: 8033109
    [Abstract] [Full Text] [Related]

  • 3. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies.
    Elashry-Stowers D, Zava DT, Speers WC, Edwards DP.
    Cancer Res; 1988 Nov 15; 48(22):6462-74. PubMed ID: 3180062
    [Abstract] [Full Text] [Related]

  • 4. Decreased progesterone binding and attenuated progesterone action in cultured human breast carcinoma cells treated with epidermal growth factor.
    Sarup JC, Rao KV, Fox CF.
    Cancer Res; 1988 Sep 15; 48(18):5071-8. PubMed ID: 3044580
    [Abstract] [Full Text] [Related]

  • 5. Immunofluorescent localization of a novel progesterone receptor(s) in a T47D-Y breast cancer cell line lacking genomic progesterone receptor expression.
    Price TM, Hansen EL, Oliver TN.
    J Soc Gynecol Investig; 2005 Dec 15; 12(8):610-6. PubMed ID: 16325750
    [Abstract] [Full Text] [Related]

  • 6. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
    Cui X, Lazard Z, Zhang P, Hopp TA, Lee AV.
    Oncogene; 2003 Oct 09; 22(44):6937-41. PubMed ID: 14534541
    [Abstract] [Full Text] [Related]

  • 7. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA, Oza BP, Colomer R, Lupu R.
    Int J Oncol; 2005 Jun 09; 26(6):1507-15. PubMed ID: 15870863
    [Abstract] [Full Text] [Related]

  • 8. An amino-terminal truncated progesterone receptor isoform, PRc, enhances progestin-induced transcriptional activity.
    Wei LL, Hawkins P, Baker C, Norris B, Sheridan PL, Quinn PG.
    Mol Endocrinol; 1996 Nov 09; 10(11):1379-87. PubMed ID: 8923464
    [Abstract] [Full Text] [Related]

  • 9. Progesterone receptor regulation in T47D human breast cancer cells: analysis by density labeling of progesterone receptor synthesis and degradation and their modulation by progestin.
    Nardulli AM, Katzenellenbogen BS.
    Endocrinology; 1988 Apr 09; 122(4):1532-40. PubMed ID: 3345726
    [Abstract] [Full Text] [Related]

  • 10. Simultaneous measurement of progesterone receptors and DNA indices by flow cytometry: characterization of an assay in breast cancer cell lines.
    Graham ML, Bunn PA, Jewett PB, Gonzalez-Aller C, Horwitz KB.
    Cancer Res; 1989 Jul 15; 49(14):3934-42. PubMed ID: 2736533
    [Abstract] [Full Text] [Related]

  • 11. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation.
    Dai D, Kumar NS, Wolf DM, Leslie KK.
    Am J Obstet Gynecol; 2001 Apr 15; 184(5):790-7. PubMed ID: 11303185
    [Abstract] [Full Text] [Related]

  • 12. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
    Liang Y, Wu J, Stancel GM, Hyder SM.
    J Steroid Biochem Mol Biol; 2005 Feb 15; 93(2-5):173-82. PubMed ID: 15860260
    [Abstract] [Full Text] [Related]

  • 13. Progestins increase insulin receptor content and insulin stimulation of growth in human breast carcinoma cells.
    Papa V, Reese CC, Brunetti A, Vigneri R, Siiteri PK, Goldfine ID.
    Cancer Res; 1990 Dec 15; 50(24):7858-62. PubMed ID: 2253226
    [Abstract] [Full Text] [Related]

  • 14. Estrogen receptor-beta messenger RNA expression in human breast tumor biopsies: relationship to steroid receptor status and regulation by progestins.
    Dotzlaw H, Leygue E, Watson PH, Murphy LC.
    Cancer Res; 1999 Feb 01; 59(3):529-32. PubMed ID: 9973194
    [Abstract] [Full Text] [Related]

  • 15. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action.
    Kumar NS, Richer J, Owen G, Litman E, Horwitz KB, Leslie KK.
    Cancer Res; 1998 May 01; 58(9):1860-5. PubMed ID: 9581825
    [Abstract] [Full Text] [Related]

  • 16. Simultaneous measurement of progesterone receptors and DNA indices by flow cytometry: analysis of breast cancer cell mixtures and genetic instability of the T47D line.
    Graham ML, Dalquist KE, Horwitz KB.
    Cancer Res; 1989 Jul 15; 49(14):3943-9. PubMed ID: 2660983
    [Abstract] [Full Text] [Related]

  • 17. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.
    Neubauer H, Adam G, Seeger H, Mueck AO, Solomayer E, Wallwiener D, Cahill MA, Fehm T.
    Climacteric; 2009 Jun 15; 12(3):230-9. PubMed ID: 19340614
    [Abstract] [Full Text] [Related]

  • 18. Cross-reactivity of a monoclonal antibody directed against an estrogen-induced protein in MCF-7 human breast cancer cells with murine Leydig cell tumor proteins.
    Melner MH, Voigt W, Puett D.
    Cancer Res; 1986 Jan 15; 46(1):328-31. PubMed ID: 3940199
    [Abstract] [Full Text] [Related]

  • 19. Pyrethroid insecticides, fenvalerate and permethrin, inhibit progesterone-induced alkaline phosphatase activity in T47D human breast cancer cells.
    Kim IY, Han SY, Kang TS, Lee BM, Choi KS, Moon HJ, Kim TS, Kang IH, Kwack SJ, Moon A, Ahn MY, Kim HS.
    J Toxicol Environ Health A; 2005 Dec 10; 68(23-24):2175-86. PubMed ID: 16326432
    [Abstract] [Full Text] [Related]

  • 20. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins.
    Sumida T, Itahana Y, Hamakawa H, Desprez PY.
    Cancer Res; 2004 Nov 01; 64(21):7886-92. PubMed ID: 15520195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.